Marker Therapeutics (MRKR) Return on Sales (2016 - 2025)
Marker Therapeutics (MRKR) posted quarterly Return on Sales of 0.02% for Q4 2025, little changed year-over-year from 0.02% in Q4 2024, and down 27.56% quarter-over-quarter from 0.02% in Q3 2025.
Marker Therapeutics (MRKR) Return on Sales (2016 - 2025) Analysis & Trends
Marker Therapeutics (MRKR) has reported Return on Sales for 9 consecutive years, with 0.02% the latest figure, recorded in Q4 2025.
- In Q4 2025, Return on Sales changed 0.0% year-over-year to 0.02%; the TTM figure through Dec 2025 stood at 0.04% (down 2.0% YoY), while the FY2025 annual figure was 0.03%, down 1.0% from the prior year.
- Return on Sales fell to 0.02% in Q4 2025 per MRKR's latest filing, from 0.02% in the prior quarter.
- Across five years, Return on Sales topped out at 0.01% in Q4 2023 and bottomed at 0.14% in Q1 2025.
- Historically, Return on Sales has averaged 0.04% across 4 years, with a median of 0.02% in 2024.
- Annual changes were most pronounced in 2024 — Return on Sales advanced 11 bps — and 2025, when it declined 11 bps.
- Marker Therapeutics' Return on Sales stood at 0.01% in 2022, then jumped by 220 bps to 0.01% in 2023, then slumped by 244 bps to 0.02% in 2024, then decreased by 12 bps to 0.02% in 2025.
- Business Quant data shows MRKR's Return on Sales at 0.02% in Q4 2025, 0.02% in Q3 2025, and 0.05% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.00% |
| 10 | Marker Therapeutics | 26.70 Mn | 14.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.05% |
| Mar 31, 2025 | -0.14% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | 0.01% |
| Sep 30, 2023 | -0.11% |
| Jun 30, 2023 | -0.13% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.05% |
| Mar 31, 2022 | -0.10% |
| Dec 31, 2020 | -2.62% |
| Sep 30, 2020 | -0.59% |
| Jun 30, 2020 | -0.40% |
| Dec 31, 2019 | -0.25% |